- Kymera Therapeutics Inc KYMR has priced its upsized underwritten public offering of 4.7 million shares at $47.00 per share, representing a discount of 3% from the last close price of $48.5 on Wednesday.
- The gross proceeds will be approximately $223.5 million.
- Underwriters have an option to purchase up to an additional 713,250 shares.
- The company says that based on existing cash and cash equivalents and marketable securities of $435.2 million and net proceeds from this offering, it will be sufficient to fund our operations into 2025.
- The offering will close by July 6.
- Price Action: KYMR shares closed at $48.50 on Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
